Year: 2026
Type: article
Source: Cell
Institutions: Broad Institute, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Massachusetts Institute of Technology, Norwegian University of Science and Technology, University of Leeds, Harvard University, University of Trento, Vall d'Hebron Institute of Oncology, National Institute for Health and Care Research
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
Funders: Damon Runyon Cancer Research Foundation, Wellcome Trust, Yorkshire Cancer Research, Heart of England NHS Foundation Trust, Cancer Research UK, National Institute for Health and Care Research, European Commission, Ministero dell’Istruzione, dell’Università e della Ricerca, Institut National Du Cancer, National Institutes of Health, HORIZON EUROPE Framework Programme, Medical Research Council, European Research Council, Leeds Biomedical Research Centre, National Cancer Institute, National Institute of Dental and Craniofacial Research
Awards: G1520204653, G15967578, G1945597809, G1949475607, G1994097943, G2134145139, G2599072453, Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response., G3386861959, G3572430074, G3692162842, G4231682250, G4328076566, G4900465205, EMbedded MONitoring, G59132117, G6697820746, G7466508714, G7647120187, Gut-liver axis and the gut vascular barrier in homeostasis and disease, Exploiting public metagenomic data to uncover cancer-microbiome relationships, G8732050839, G8787940563, Exploiting Public Metagenomic Data to Uncover Cancer-Microbiome Relationships, G923756654
OpenAlex ID: W7160304102